Venus Medtech (Hangzhou) Inc.
VMTHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $5 | $13 |
| - Cash | $0 | $1 | $2 | $3 |
| + Debt | $0 | $1 | $1 | $0 |
| Enterprise Value | $0 | $0 | $4 | $10 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -4.2% | 20.9% | -2.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 78.1% | 79.2% | 77.3% | 78% |
| EBITDA | -$1 | -$1 | -$1 | -$0 |
| % Margin | -130.2% | -111.5% | -245.9% | -77.9% |
| Net Income | -$1 | -$1 | -$1 | -$0 |
| % Margin | -151.7% | -143.2% | -260.2% | -89.8% |
| EPS Diluted | -1.63 | -1.61 | -2.42 | -0.85 |
| % Growth | -1.2% | 33.5% | -184.7% | – |
| Operating Cash Flow | $0 | -$1 | -$1 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$1 | -$1 | -$1 |